Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H10ClN3O2 |
| Molecular Weight | 239.658 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(OC)C=C2C(N)=NC(Cl)=NC2=C1
InChI
InChIKey=HWIIAAVGRHKSOJ-UHFFFAOYSA-N
InChI=1S/C10H10ClN3O2/c1-15-7-3-5-6(4-8(7)16-2)13-10(11)14-9(5)12/h3-4H,1-2H3,(H2,12,13,14)
| Molecular Formula | C10H10ClN3O2 |
| Molecular Weight | 239.658 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/9986714Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/2863379
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9986714
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/2863379
2-Chloro-6,7-dimethoxy-4-quinazolinamine is building block for preparing terazosine and its analogues, α1-adrenoceptor antagonists
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Development and validation of a reversed-phase HPLC method for monitoring of synthetic reactions during the manufacture of a key intermediate of an anti-hypertensive drug. | 2006-10 |
|
| Prediction of genotoxicity of chemical compounds by statistical learning methods. | 2005-06 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:33:06 GMT 2025
by
admin
on
Mon Mar 31 21:33:06 GMT 2025
|
| Record UNII |
FG7Z4T71Y4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
245-821-7
Created by
admin on Mon Mar 31 21:33:06 GMT 2025 , Edited by admin on Mon Mar 31 21:33:06 GMT 2025
|
PRIMARY | |||
|
90235
Created by
admin on Mon Mar 31 21:33:06 GMT 2025 , Edited by admin on Mon Mar 31 21:33:06 GMT 2025
|
PRIMARY | |||
|
1225452
Created by
admin on Mon Mar 31 21:33:06 GMT 2025 , Edited by admin on Mon Mar 31 21:33:06 GMT 2025
|
PRIMARY | |||
|
DTXSID3057694
Created by
admin on Mon Mar 31 21:33:06 GMT 2025 , Edited by admin on Mon Mar 31 21:33:06 GMT 2025
|
PRIMARY | |||
|
FG7Z4T71Y4
Created by
admin on Mon Mar 31 21:33:06 GMT 2025 , Edited by admin on Mon Mar 31 21:33:06 GMT 2025
|
PRIMARY | |||
|
23680-84-4
Created by
admin on Mon Mar 31 21:33:06 GMT 2025 , Edited by admin on Mon Mar 31 21:33:06 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> IMPURITY |
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
USP
|